Cargando…
p18 inhibits reprogramming through inactivation of Cdk4/6
Pluripotent stem cells (PSCs), including embryonic and induced pluripotent stem cells (iPSCs), show atypical cell cycle regulation characterized by a high proliferation rate and a shorter G1 phase compared with somatic cells. The mechanisms by which somatic cells remodel their cell cycle to achieve...
Autores principales: | Zhu, Shaohua, Cao, Jiani, Sun, Hongyan, Liu, Kun, Li, Yaqiong, Zhao, Tongbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971472/ https://www.ncbi.nlm.nih.gov/pubmed/27484146 http://dx.doi.org/10.1038/srep31085 |
Ejemplares similares
-
Metabolic Reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities
por: Franco, Jorge, et al.
Publicado: (2020) -
CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAF(V600) Melanoma via a p53 Dependent Pathway
por: Santiappillai, Nancy T., et al.
Publicado: (2021) -
Induction of prolonged early G(1) arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1
por: Chiron, David, et al.
Publicado: (2013) -
The transcriptome of CDK4/6 inhibition
por: Knudsen, Erik S., et al.
Publicado: (2017) -
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
por: Pack, Lindsey R., et al.
Publicado: (2021)